ASBP (Aspire-Lakewood Holdings) Current Accrued Expense: $0.71 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASBP Aspire-Lakewood Holdings Inc ASBP
11 GF Score
Price $9.25
! 2 Warning Signs
View Full Analysis

What is Aspire-Lakewood Holdings Current Accrued Expense?

Aspire-Lakewood Holdings ASBP +2.42% 11 Current Accrued Expense is $0.71 Mil as of Jun. 2026. GuruFocus rates ASBP with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Aspire-Lakewood Holdings's Current Accrued Expense for the quarter that ended in Jun. 2026 was $0.71 Mil.

Aspire-Lakewood Holdings's quarterly Current Accrued Expense declined from Dec. 2025 ($1.01 Mil) to Mar. 2026 ($0.44 Mil) but then increased from Mar. 2026 ($0.44 Mil) to Jun. 2026 ($0.71 Mil).

Aspire-Lakewood Holdings's annual Current Accrued Expense stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($1.01 Mil).

Aspire-Lakewood Holdings Current Accrued Expense Related Terms

Aspire-Lakewood Holdings Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Aspire-Lakewood Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspire-Lakewood Holdings Current Accrued Expense Chart

Aspire-Lakewood Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
0.00 0.00 0.00 1.01

Aspire-Lakewood Holdings Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.27 1.01 0.44 0.71
ASBP
11GF Score
Aspire-Lakewood Holdings Inc ASBP
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspire-Lakewood Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.71 Mil mean?
Aspire-Lakewood Holdings (ASBP) has a Current Accrued Expense of $0.71 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Aspire-Lakewood Holdings and its competitors.
Is Aspire-Lakewood Holdings' Current Accrued Expense too high?
Aspire-Lakewood Holdings' current Current Accrued Expense is $0.71 Mil. Overall, Aspire-Lakewood Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Aspire-Lakewood Holdings' Current Accrued Expense compare to PDSB and KPRX?
Aspire-Lakewood Holdings' Current Accrued Expense of $0.71 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Aspire-Lakewood Holdings and its competitors. Aspire-Lakewood Holdings's current Current Accrued Expense is $0.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspire-Lakewood Holdings stock overvalued right now?
Aspire-Lakewood Holdings (ASBP) has a current Current Accrued Expense of $0.71 Mil. The current Current Accrued Expense is $0.71 Mil. Aspire-Lakewood Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Aspire-Lakewood Holdings (ASBP), the current Current Accrued Expense is $0.71 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aspire-Lakewood Holdings Business Description

Address 23150 Fashion Drive, Suite 232, Estero, FL, USA, 33928
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
11GF Score

Get the complete analysis for ASBP

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.25
Price